• Clariane reaffirmed 2023-2026 targets for approximately 5% annual organic revenue growth and a 100-150-basis-point EBITDA margin improvement.
• Leverage remains targeted below 5.5 times at end-2026, falling to approximately 5 times at end-2028.
• The 2025-2028 outlook projects approximately 4% annual pro forma revenue growth, with annual EBITDA growth of 7%-9%.
• Operating-company EBITDA is forecast to grow 11%-14% annually over the same period.
• Nine-month revenue reached €4.05 billion, with organic growth of 4.7%; third-quarter organic growth accelerated to 4.9%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clariane SE published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.